Kadmon (KDMN) Stock Price, News & Analysis

Company Overview

Kadmon is a clinical-stage biopharmaceutical company that discovers, develops and delivers transformative therapies for unmet medical needs. Its clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies.

Key Stats

• Today's Range: $9.50 to $9.50
• 50-Day Range: $9.50 to $9.50
• 52-Week Range: $3.19 to $9.50
• Volume: 1,052 shs
• Average Volume: 5.11 million shs
• Market Capitalization: $1.70 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

KDMN Stock Analysis - Frequently Asked Questions

When did Kadmon IPO?

Kadmon (KDMN) raised $101 million in an initial public offering (IPO) on Wednesday, July 27th 2016. The company issued 5,600,000 shares at a price of $16.00-$20.00 per share. Citigroup and Jefferies acted as the underwriters for the IPO and JMP Securities and H.C. Wainwright & Co. were co-managers.

What other stocks do shareholders of Kadmon own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Kadmon investors own include Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Organigram (OGI), KushCo (KSHB), Zosano Pharma (ZSAN) and Bionano Genomics (BNGO).

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Manufacturing
• Industry: Pharmaceutical Preparation Manufacturing
• Sub-Industry: N/A
• Current Symbol: NYSE:KDMN
• CUSIP: N/A
• CIK: N/A
• Web: N/A
• Phone: 12123086000
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 178,521,000
• Free Float: N/A
• Market Cap: $1.70 billion
• Optionable: Optionable
• Beta: N/A